Geron Corp (NAS:GERN)
$ 3.3 0 (0%) Market Cap: 1.99 Bil Enterprise Value: 1.74 Bil PE Ratio: 0 PB Ratio: 6.73 GF Score: 37/100

Geron Corp Investor Event Transcript

Jun 14, 2023 / 12:00PM GMT
Release Date Price: $3.09 (-5.21%)
Operator

Hello, and welcome to the Geron Virtual R&D Investor Event Call. (Operator Instructions) I would now like to turn the conference over to Aron Feingold. Please go ahead.

Aron Feingold
Geron Corporation - VP of IR & Corporate Communications

Good morning, everyone, and welcome to our Investor event. I am Aron Feingold, Geron's Vice President of Investor Relations and Corporate Communications. I'm thrilled to be joined today by 2 key opinion leaders in hematologic malignancies and leading investigators of our imetelstat clinical study. Professor Uwe Platzbecker, M.D. University Hospital, Leipzig; and Professor Rami Komrokji, Moffitt Cancer Center as well as the members of Geron's management team. Dr. John Scarlett, Chairman and Chief Executive Officer; Olivia Bloom, Executive Vice President and Chief Financial Officer. Dr. Faye Feller, Executive Vice President and Chief Medical Officer; and Anil Kapur, Executive Vice President of Corporate Strategy and Chief Commercial Officer. These speakers will cover the agenda topic shown on this slide. As you can see,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot